ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)

Patent Applications and Registrations

Patent applications and USPTO patent grants for ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR).The latest application filed is for "unsaturated heterocycloalkyl and heteroaromatic acyl hydrazone linkers, methods and uses thereof".

Company Profile

21.9.22

ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) - Toronto CA
Ontario Institute for Cancer Research (OICR) - OICR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Unsaturated Heterocycloalkyl And Heteroaromatic Acyl Hydrazone Linkers, Methods And Uses Thereof App 20220267281 - MAMAI; Ahmed ; et al.	2022-08-25
Compounds and methods for treating nematode infections Grant 11,364,234 - Roy , et al. June 21, 2	2022-06-21
Amide-based Proteolysis Modulators Of B-rapidly Accelerated Fibrosarcoma (braf) And Associated Uses App 20220125936 - Sicheri; Frank ; et al.	2022-04-28
Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof Grant 11,242,351 - Al-awar , et al. February 8, 2	2022-02-08
Quinolone compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders Grant 11,192,880 - Isaac , et al. December 7, 2	2021-12-07
Targeting the histone pathway to detect and overcome anthracyclin resistance Grant 11,015,226 - Spears , et al. May 25, 2	2021-05-25
Heterocyclic Acyl Hydrazone Linkers, Methods And Uses Thereof App 20210106694 - Al-awar; Rima ; et al.	2021-04-15
Tricyclic Inhibitors Of The Bcl6 Btb Domain Protein-protein Interaction And Uses Thereof App 20210053978 - Al-awar; Rima ; et al.	2021-02-25
Acyl Hydrazone Linkers, Methods And Uses Thereof App 20200397916 - Al-Awar; Rima ; et al.	2020-12-24
Inhibitors Of The Bcl6 Btb Domain Protein-protein Interaction And Uses Thereof App 20200331921 - Al-awar; Rima ; et al.	2020-10-22
Novel Quinolone Compounds As Inhibitors Of The Bcl6 Btb Domain Protein-protein Interaction And/or As Bcl6 Degraders App 20200325119 - Isaac; Methvin ; et al.	2020-10-15
Novel Deuterated Compounds As Inhibitors Of The Bcl6 Btb Domain Protein-protein Interaction And/or As Bcl6 Degraders App 20200308147 - Isaac; Methvin ; et al.	2020-10-01
Biopsy-driven genomic signature for prostate cancer prognosis Grant 10,745,760 - Boutros , et al. A	2020-08-18
Cancer Risk Based On Tumour Clonality App 20200032349 - ESPIRITU; Shadrielle Melijah G. ; et al.	2020-01-30
Mitochondrial Dna Prostate Cancer Marker And Related Systems And Methods App 20190112672 - Hopkins; Julia A. ; et al.	2019-04-18
Multi-modal Prostate Cancer Marker App 20190055608 - Boutros; Paul ; et al.	2019-02-21
Gene Signature of Residual Risk Following Endocrine Treatment in Early Breast Cancer App 20190010553 - Bayani; Jane ; et al.	2019-01-10
Targeting the Histone Pathway to Detect and Overcome Anthracyclin Resistance App 20180282819 - Spears; Melanie ; et al.	2018-10-04
Biopsy-Driven Genomic Signature for Prostate Cancer Prognosis App 20160333421 - BOUTROS; Paul ; et al.	2016-11-17
Method for Identifying a Target Molecular Profile Associated with a Target Cell Population App 20150294062 - Quon; Gerald ; et al.	2015-10-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.